ZURCHER KANTONALBANK FINANCE (GUERNSEY) LIMITED | Real-time Bid/Ask 07:39:01 2024-06-13 am EDT | ||
| 97.75 USD / 98.25 USD | -0.02% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 98.02 | +0.64% |
| 24-06-11 | 97.4 | +0.28% |
Delayed Quote Swiss Exchange
Last update June 12, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | ZKB |
| Z0980Z | |
| ISIN | CH1329111327 |
| Date issued | 2024-03-11 |
| Strike | 54.36 $ |
| Maturity | 2025-03-11 (272 Days) |
| Parity | 0.05 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.6 $ |
|---|---|
| Lowest since issue | 95.97 $ |
| Spread | 5 $ |
| Spread % | 0.51% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.41
USD
Average target price
53.19
USD
Spread / Average Target
+25.43%
- Stock Market
- Certificates
- Z0980Z Certificat
